论文部分内容阅读
目的探讨乳腔镜行保乳手术联合新辅助化疗治疗乳腺癌的临床疗效。方法选取2012年3月-2013年9月该院接受治疗的100例乳腺癌患者,随机分为A组和B组各50例,A组只应用乳腔镜保乳手术,B组给予乳腔镜行保乳手术联合新辅助化疗,比较2组临床疗效。结果 B组患者的总有效率为80%显著高于A组的60%,差异有统计学意义(P<0.05)。结论乳腔镜行保乳手术联合新辅助化疗治疗乳腺癌有很好的临床疗效,值得临床推广应用。
Objective To investigate the clinical efficacy of laparoscopic breast-conserving surgery combined with neoadjuvant chemotherapy in the treatment of breast cancer. Methods A total of 100 breast cancer patients treated in our hospital from March 2012 to September 2013 were randomly divided into group A and group B (50 cases each). Group A received only breast-conserving surgery and group B received breast-milk Mirror breast conservative surgery combined with neoadjuvant chemotherapy, the clinical efficacy of two groups were compared. Results The total effective rate of group B was 80%, which was significantly higher than that of group A (60%), the difference was statistically significant (P <0.05). Conclusions Laryngeal mirror breast conservative surgery combined with neoadjuvant chemotherapy in the treatment of breast cancer has a good clinical effect, it is worthy of clinical application.